A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
The purpose of this trial is to assess the clinical effect of CH-1504 at doses of 0.25, 0.5 and 1.0 mg per day in patients with active rheumatoid arthritis by determining the proportion of patients achieving an American College of Rheumatology (ACR) 20% improvement response.
Epistemonikos ID: a469320efaf4b1941af8bc7979bb1fc3c7f71431
First added on: Mar 23, 2022